E. Nabatchikova, T. Rozina, E. Nikulkina, E. Tanaschuk, S. A. Parfenova, N.Y. Nyaikina, L. V. Dubrovskaya, E. Starostina, D. Abdurakhmanov
{"title":"消除肝移植候诊患者的丙型肝炎病毒","authors":"E. Nabatchikova, T. Rozina, E. Nikulkina, E. Tanaschuk, S. A. Parfenova, N.Y. Nyaikina, L. V. Dubrovskaya, E. Starostina, D. Abdurakhmanov","doi":"10.32756/0869-5490-2021-4-29-35","DOIUrl":null,"url":null,"abstract":"To study the changes in liver function and portal hypertension, and clinical outcomes after elimination of hepatitis C virus (HCV) by direct-acting antiviral agents in patients awaiting an orthotopic liver transplantation (OLT).","PeriodicalId":10353,"journal":{"name":"Clinical pharmacology and therapy","volume":"4 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Elimination of hepatitis C virus in patients on the waiting list for liver transplantation\",\"authors\":\"E. Nabatchikova, T. Rozina, E. Nikulkina, E. Tanaschuk, S. A. Parfenova, N.Y. Nyaikina, L. V. Dubrovskaya, E. Starostina, D. Abdurakhmanov\",\"doi\":\"10.32756/0869-5490-2021-4-29-35\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"To study the changes in liver function and portal hypertension, and clinical outcomes after elimination of hepatitis C virus (HCV) by direct-acting antiviral agents in patients awaiting an orthotopic liver transplantation (OLT).\",\"PeriodicalId\":10353,\"journal\":{\"name\":\"Clinical pharmacology and therapy\",\"volume\":\"4 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-11-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical pharmacology and therapy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.32756/0869-5490-2021-4-29-35\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical pharmacology and therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.32756/0869-5490-2021-4-29-35","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Elimination of hepatitis C virus in patients on the waiting list for liver transplantation
To study the changes in liver function and portal hypertension, and clinical outcomes after elimination of hepatitis C virus (HCV) by direct-acting antiviral agents in patients awaiting an orthotopic liver transplantation (OLT).
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
